BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $565,458 | +8.5% | 14,983 | +31.0% | 0.01% | -6.7% |
| Q2 2023 | $521,206 | +14.8% | 11,440 | +2.2% | 0.02% | 0.0% |
| Q1 2023 | $453,826 | -51.4% | 11,189 | -39.0% | 0.02% | -28.6% |
| Q4 2022 | $934,000 | -5.4% | 18,332 | 0.0% | 0.02% | -25.0% |
| Q3 2022 | $987,000 | -16.2% | 18,332 | 0.0% | 0.03% | -9.7% |
| Q2 2022 | $1,178,000 | -61.9% | 18,332 | -51.4% | 0.03% | -40.4% |
| Q4 2020 | $3,091,000 | 0.0% | 37,715 | 0.0% | 0.05% | -20.0% |
| Q2 2020 | $3,091,000 | -77.6% | 37,715 | -77.3% | 0.06% | -64.9% |
| Q1 2020 | $13,799,000 | +9.7% | 165,996 | +9.8% | 0.18% | +29.4% |
| Q4 2019 | $12,584,000 | -13.1% | 151,235 | -8.6% | 0.14% | -21.4% |
| Q3 2019 | $14,474,000 | -65.3% | 165,467 | -67.5% | 0.18% | +75.0% |
| Q2 2019 | $41,726,000 | +54.0% | 509,479 | +52.9% | 0.10% | +48.6% |
| Q1 2019 | $27,094,000 | +28.8% | 333,216 | +4.3% | 0.07% | +14.8% |
| Q4 2018 | $21,029,000 | -18.1% | 319,498 | -4.1% | 0.06% | -4.7% |
| Q3 2018 | $25,679,000 | -2.0% | 333,107 | -6.1% | 0.06% | -8.6% |
| Q2 2018 | $26,207,000 | +13.9% | 354,917 | +0.3% | 0.07% | +12.9% |
| Q1 2018 | $23,013,000 | -8.3% | 353,830 | -8.8% | 0.06% | -10.1% |
| Q4 2017 | $25,088,000 | +10.3% | 388,111 | +7.0% | 0.07% | +3.0% |
| Q3 2017 | $22,755,000 | +5.9% | 362,631 | +2.2% | 0.07% | +3.1% |
| Q2 2017 | $21,490,000 | +7.1% | 354,978 | -8.3% | 0.06% | +3.2% |
| Q1 2017 | $20,070,000 | +19.5% | 387,000 | +2.2% | 0.06% | +12.5% |
| Q4 2016 | $16,793,000 | -5.2% | 378,724 | +1.7% | 0.06% | -6.7% |
| Q3 2016 | $17,718,000 | +58.0% | 372,222 | +50.1% | 0.06% | +50.0% |
| Q2 2016 | $11,215,000 | -0.5% | 248,004 | -9.6% | 0.04% | -2.4% |
| Q1 2016 | $11,269,000 | +11.9% | 274,321 | +3.9% | 0.04% | +13.9% |
| Q4 2015 | $10,068,000 | +17.3% | 263,904 | +1.0% | 0.04% | +12.5% |
| Q3 2015 | $8,581,000 | -42.3% | 261,205 | +22.7% | 0.03% | -38.5% |
| Q2 2015 | $14,882,000 | +36.8% | 212,816 | +34.0% | 0.05% | +36.8% |
| Q1 2015 | $10,879,000 | -6.0% | 158,823 | +0.6% | 0.04% | -7.3% |
| Q4 2014 | $11,570,000 | +2.6% | 157,865 | +0.5% | 0.04% | 0.0% |
| Q3 2014 | $11,279,000 | +6.0% | 157,148 | +6.8% | 0.04% | +5.1% |
| Q2 2014 | $10,639,000 | -6.0% | 147,148 | -4.4% | 0.04% | -11.4% |
| Q1 2014 | $11,322,000 | +11.1% | 153,870 | +5.0% | 0.04% | +7.3% |
| Q4 2013 | $10,192,000 | -46.6% | 146,549 | -49.5% | 0.04% | -50.0% |
| Q3 2013 | $19,076,000 | -9.8% | 290,399 | -4.9% | 0.08% | -16.3% |
| Q2 2013 | $21,145,000 | – | 305,249 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |